Revenue (Quarterly) Chart

View Revenue (Quarterly) for CWQXF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 258.43M
March 31, 2026 253.92M
December 31, 2025 254.92M
September 30, 2025 252.90M
June 30, 2025 248.74M
March 31, 2025 223.54M
December 31, 2024 226.71M
September 30, 2024 232.96M
June 30, 2024 236.49M
March 31, 2024 235.58M
December 31, 2023 232.19M
September 30, 2023 223.35M
June 30, 2023 233.68M
March 31, 2023 234.78M
December 31, 2022 209.40M
September 30, 2022 221.12M
June 30, 2022 224.08M
March 31, 2022 234.77M
December 31, 2021 216.87M
September 30, 2021 177.51M
June 30, 2021 170.27M
March 31, 2021 177.08M
December 31, 2020 175.92M
September 30, 2020 166.79M
June 30, 2020 157.17M
Date Value
March 31, 2020 152.14M
December 31, 2019 153.47M
September 30, 2019 153.50M
June 30, 2019 152.20M
March 31, 2019 156.18M
December 31, 2018 158.54M
September 30, 2018 156.49M
June 30, 2018 159.66M
March 31, 2018 165.54M
December 31, 2017 158.17M
September 30, 2017 160.12M
June 30, 2017 143.10M
March 31, 2017 146.17M
December 31, 2016 150.98M
September 30, 2016 159.47M
June 30, 2016 115.87M
March 31, 2016 101.06M
December 31, 2015 100.01M
September 30, 2015 98.04M
June 30, 2015 96.98M
March 31, 2015 96.02M
December 31, 2014 110.62M
September 30, 2014 119.91M
June 30, 2014 127.67M
March 31, 2014 126.87M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Pandox AB 233.33M
Fabege AB 119.82M
Gyrodyne LLC --
IRSA Inversiones y Representaciones SA 101.81M
Nam Tai Property, Inc. 4.948M